NOTICE OF DISCIPLINARY ACTION

NON-MEMBER:

DAGUO WANG

NYMEX RULE: 432. General Offenses (in part)

It shall be an offense:

L. 1. to fail to appear before the Board, Exchange staff or any investigative or hearing committee at a duly convened hearing, scheduled staff interview or in connection with any investigation.

FINDINGS:

On July 5, 2022, the Chief Regulatory Officer of CME Group’s Market Regulation Department issued a charge against DaGuo Wang for violating Rule 432.L.1., based on allegations that Wang failed to appear before Exchange staff for a scheduled interview.

On December 15, 2022, a Hearing Panel Chair of the NYMEX Business Conduct Committee (“BCC”) first determined that Wang, having failed to submit a written answer to the charge issued against him, was deemed to have admitted the charge. Wang therefore waived his right to a hearing on the merits of the charge. Pursuant to Rule 408.F., a BCC Panel then found Wang guilty of committing the admitted charge and held a penalty hearing thereafter.

PENALTY:

Based on the record and the Panel’s findings and conclusions, the Panel permanently suspended Wang from access to any trading floor owned or controlled by CME Group and from direct and indirect access to any designated contract market, derivatives clearing organization or swap execution facility owned or controlled by CME Group, as well as permanently restricted Wang from having a business affiliation with, be employed by or have a financial or beneficial interest in a Member or broker association.